|4Nov 29, 4:11 PM ET

Erlander Mark 4

4 · Cardiff Oncology, Inc. · Filed Nov 29, 2022

Insider Transaction Report

Form 4
Period: 2022-11-25
Erlander Mark
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-11-25$1.43/sh+10,000$14,30024,481 total

Documents

1 file
  • 4
    wf-form4_166975625707899.xmlPrimary

    FORM 4